Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine
Crossref DOI link: https://doi.org/10.17352/jvi.000037
Published Online: 2021-01-25
Published Print: 2021-01-25
Update policy: https://doi.org/10.17352/jvi
Reynaldo, Oliva-Hernandez
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25